Drugs / SKP-0141
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06738901 | Mar 2025 → Jul 2026 overdue | severe hemophilia A | SK Plasma Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SKP-0141 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06738901 ↗ |